JTL
RLMD icon

Jupiter Topco LLC’s Relmada Therapeutics RLMD Stock Holding History

Jupiter Topco LLC’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.3M Buy
+11,164,803
New +$78M 0.03% 358

Other funds holding RLMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SSC
Spruce Street Capital New York $510M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco LLC's RLMD Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in Relmada Therapeutics (RLMD) in Q2 2026: 11,164,803 shares worth $77.3M. The stake represents 0.03% of the portfolio and ranks #358 among its holdings.

115 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

  • Jupiter Topco LLC held 11,164,803 shares of Relmada Therapeutics worth $77.3M as of Q2 2026.
  • Relmada Therapeutics was a new Jupiter Topco LLC position in Q2 2026.
  • Relmada Therapeutics made up 0.03% of Jupiter Topco LLC's portfolio in Q2 2026, its #358 holding.
  • 115 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.